UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 27

Sortiert nach

Fecundity, pregnancy outcomes, and breastfeeding in patients with inflammatory bowel disease: a large cohort survey

Scandinavian journal of gastroenterology, 2013-04, Vol.48 (4), p.427-432

2013

Volltextzugriff (PDF)

Differences between childhood‐ and adulthood‐onset inflammatory bowel disease: the CAROUSEL study from GETECCU

Alimentary pharmacology & therapeutics, 2019-02, Vol.49 (4), p.419-428

2019

Volltextzugriff (PDF)

Rapidity of clinical response to adalimumab and improvement of quality of life in luminal Crohn's disease: RAPIDA study

Gastroenterología y hepatología, 2022-03, Vol.45 (3), p.165-176

2022

Volltextzugriff (PDF)

Risk Factors for COVID-19 in Inflammatory Bowel Disease: A National, ENEIDA-Based Case-Control Study (COVID-19-EII)

Journal of clinical medicine, 2022-12, Vol.11 (24), p.7540

2022

Volltextzugriff (PDF)

Nationwide COVID-19-EII Study: Incidence, Environmental Risk Factors and Long-Term Follow-Up of Patients with Inflammatory Bowel Disease and COVID-19 of the ENEIDA Registry

Journal of clinical medicine, 2022-01, Vol.11 (2), p.421

2022

Volltextzugriff (PDF)

Antitumor Necrosis Factor Agents to Treat Endoscopic Postoperative Recurrence of Crohn's Disease: A Nationwide Study With Propensity-Matched Score Analysis

Clinical and translational gastroenterology, 2020-08, Vol.11 (8), p.e00218-e00218

2020

Volltextzugriff (PDF)

Adalimumab or Infliximab for the Prevention of Early Postoperative Recurrence of Crohn Disease: Results From the ENEIDA Registry

Inflammatory bowel diseases, 2019-10, Vol.25 (11), p.1862-1870

2019

Volltextzugriff (PDF)

Prospective, Observational, Cross-Sectional Study of Intestinal Infections among Acutely Active Inflammatory Bowel Disease Patients

Digestion, 2009-01, Vol.80 (1), p.25-29

2009

Volltextzugriff (PDF)

Effectiveness and Safety of Ustekinumab in Ulcerative Colitis: Real-world Evidence from the ENEIDA Registry

Journal of Crohn's and colitis, 2021-04, Vol.15 (11), p.1846-1851

2021

Volltextzugriff (PDF)

Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients With Inflammatory Bowel Disease: Results From the Eneida Registry

Inflammatory bowel diseases, 2020-03, Vol.26 (4), p.606-616

2020

Volltextzugriff (PDF)

Effectiveness and Safety of Ustekinumab in Elderly Patients with Crohn’s Disease: Real World Evidence From the ENEIDA Registry

Journal of Crohn's and colitis, 2023-01, Vol.17 (1), p.83-91

2023

Volltextzugriff (PDF)

86 - RESULTADOS DE LA TRANSICIÓN DE ADALIMUMAB DE REFERENCIA AL BIOSIMILAR SB5 EN PACIENTES CON ENFERMEDAD DE CROHN EN LA PRÁCTICA CLÍNICA: SUBANÁLISIS DE LOS PACIENTES ESPAÑOLES DEL ESTUDIO PROPER TRAS 48 SEMANAS DE SEGUIMIENTO

Gastroenterología y hepatología, 2023-03, Vol.46, p.S118-S118

2023

Volltextzugriff (PDF)

Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study

Journal of clinical medicine, 2021-06, Vol.10 (13), p.2885

2021

Volltextzugriff (PDF)

105 - ESTUDIO PROSPECTIVO SOBRE EL PERFIL DE SEGURIDAD DE UN CURSO CONVENCIONAL DE CORTICOIDES SISTÉMICOS EN LA ENFERMEDAD INFLAMATORIA INTESTINAL

Gastroenterología y hepatología, 2023-03, Vol.46, p.S137-S137

2023

Volltextzugriff (PDF)

ENSAYO CLÍNICO ALEATORIZADO COMPARATIVO DEL EFECTO DE MEGABOLOS DE CORTICOIDES INTRAVENOSOS AÑADIDOS A LOS CORTICOIDES ORALES EN EL TRATAMIENTO DE LA CU CON ACTIVIDAD MODERADA

Gastroenterología y hepatología, 2023-03, Vol.46, p.S28-S28

2023

Volltextzugriff (PDF)

Risk of Immunomediated Adverse Events and Loss of Response to Infliximab in Elderly Patients with Inflammatory Bowel Disease: A Cohort Study of the ENEIDA Registry

Journal of Crohn's and colitis, 2022-07, Vol.16 (6), p.946-953

2022

Volltextzugriff (PDF)

Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDA

Pharmaceutics, 2024-05, Vol.16 (5), p.629

2024

Volltextzugriff (PDF)

33 - LA INFECCIÓN POR VIH SE ASOCIA CON UN FENOTIPO MENOS AGRESIVO DE ENFERMEDAD INFLAMATORIA INTESTINAL. ESTUDIO MULTICÉNTRICO BASADO EN EL REGISTRO ENEIDA

Gastroenterología y hepatología, 2023-03, Vol.46, p.S65-S65

2023

Volltextzugriff (PDF)

ES FACTIBLE LA SUSPENSIÓN DEL TRATAMIENTO ANTI-TNF EN PACIENTES CON ENFERMEDAD INFLAMATORIA INTESTINAL EN REMISIÓN SIN AUMENTAR EL RIESGO DE RECIDIVA? RESULTADOS DEL ENSAYO CLÍNICO ALEATORIZADO DE GETECCU (EXIT)

Gastroenterología y hepatología, 2023-03, Vol.46, p.S19-S19

2023

Volltextzugriff (PDF)

Rapidity of clinical response to adalimumab and improvement of quality of life in luminal Crohn's disease: RAPIDA study

Gastroenterología y Hepatología (English Edition), 2022-03, Vol.45 (3), p.165-176

2022

Volltextzugriff (PDF)

Correction: Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study. J. Clin. Med. 2021, 10 , 2885

Journal of clinical medicine, 2022-09, Vol.11 (19), p.5816

2022

Volltextzugriff (PDF)

Su1865 – Real-World Short-Term Effectivenes of Ustekinumab in Crohn’s Disease: Results from the Eneida Registry

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.S-641-S-642

2019

Volltextzugriff (PDF)

Pernicious anaemia in triplets. A case report an literature review

Gastroenterología y hepatología, 2007-12, Vol.30 (10), p.580-582

2007

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(27)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Ingenta
(21)
EZB*
(17)
ScienceDirect
(14)
MEDLINE
(9)
IngentaConnect Journals
(8)
Journals@Ovid Ovid Full Text
(8)
Oxford journals
(5)
Oxford Journals 2020 Medicine
(5)
Wiley Online Library
(3)
Publisher website
(2)
Taylor & Francis Online
(1)
Wiley Online Library
(1)
Springer Nature - Connect here FIRST to enable access
(1)
Access via Taylor & Francis
(1)
Taylor & Francis
(1)

10 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Fecundity, pregnancy outcomes, and breastfeeding in patients with inflammatory bowel disease: a large cohort survey

Differences between childhood‐ and adulthood‐onset inflammatory bowel disease: the CAROUSEL study from GETECCU

Rapidity of clinical response to adalimumab and improvement of quality of life in luminal Crohn's disease: RAPIDA study

Risk Factors for COVID-19 in Inflammatory Bowel Disease: A National, ENEIDA-Based Case-Control Study (COVID-19-EII)

Nationwide COVID-19-EII Study: Incidence, Environmental Risk Factors and Long-Term Follow-Up of Patients with Inflammatory Bowel Disease and COVID-19 of the ENEIDA Registry

Antitumor Necrosis Factor Agents to Treat Endoscopic Postoperative Recurrence of Crohn's Disease: A Nationwide Study With Propensity-Matched Score Analysis

Adalimumab or Infliximab for the Prevention of Early Postoperative Recurrence of Crohn Disease: Results From the ENEIDA Registry

Prospective, Observational, Cross-Sectional Study of Intestinal Infections among Acutely Active Inflammatory Bowel Disease Patients

Effectiveness and Safety of Ustekinumab in Ulcerative Colitis: Real-world Evidence from the ENEIDA Registry

Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients With Inflammatory Bowel Disease: Results From the Eneida Registry

Effectiveness and Safety of Ustekinumab in Elderly Patients with Crohn’s Disease: Real World Evidence From the ENEIDA Registry

86 - RESULTADOS DE LA TRANSICIÓN DE ADALIMUMAB DE REFERENCIA AL BIOSIMILAR SB5 EN PACIENTES CON ENFERMEDAD DE CROHN EN LA PRÁCTICA CLÍNICA: SUBANÁLISIS DE LOS PACIENTES ESPAÑOLES DEL ESTUDIO PROPER TRAS 48 SEMANAS DE SEGUIMIENTO

Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study

105 - ESTUDIO PROSPECTIVO SOBRE EL PERFIL DE SEGURIDAD DE UN CURSO CONVENCIONAL DE CORTICOIDES SISTÉMICOS EN LA ENFERMEDAD INFLAMATORIA INTESTINAL

91 - ESTUDIO PROSPECTIVO SOBRE LA SATISFACCIÓN Y EL IMPACTO EN LA CALIDAD DE VIDA DEL TRATAMIENTO CON CORTICOIDES EN PACIENTES CON ENFERMEDAD INFLAMATORIA INTESTINAL

ENSAYO CLÍNICO ALEATORIZADO COMPARATIVO DEL EFECTO DE MEGABOLOS DE CORTICOIDES INTRAVENOSOS AÑADIDOS A LOS CORTICOIDES ORALES EN EL TRATAMIENTO DE LA CU CON ACTIVIDAD MODERADA

Risk of Immunomediated Adverse Events and Loss of Response to Infliximab in Elderly Patients with Inflammatory Bowel Disease: A Cohort Study of the ENEIDA Registry

Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDA

33 - LA INFECCIÓN POR VIH SE ASOCIA CON UN FENOTIPO MENOS AGRESIVO DE ENFERMEDAD INFLAMATORIA INTESTINAL. ESTUDIO MULTICÉNTRICO BASADO EN EL REGISTRO ENEIDA

ES FACTIBLE LA SUSPENSIÓN DEL TRATAMIENTO ANTI-TNF EN PACIENTES CON ENFERMEDAD INFLAMATORIA INTESTINAL EN REMISIÓN SIN AUMENTAR EL RIESGO DE RECIDIVA? RESULTADOS DEL ENSAYO CLÍNICO ALEATORIZADO DE GETECCU (EXIT)

Rapidity of clinical response to adalimumab and improvement of quality of life in luminal Crohn's disease: RAPIDA study

Correction: Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study. J. Clin. Med. 2021, 10 , 2885

Su1865 – Real-World Short-Term Effectivenes of Ustekinumab in Crohn’s Disease: Results from the Eneida Registry

Pernicious anaemia in triplets. A case report an literature review

Tu1996 Prevalence and Factors Associated With Fatigue in Patients With Inflammatory Bowel Disease: A Multicenter Study

Suchergebnisse filtern